Rhenovia Pharma Language Contact
Search
   
    HomeCompanyScience & TechnologyServices & ProductsInvestors & MarketNews & EventsContact Us    
    Rhenovia Pharma    
   
RSS

Stay connected & subscribe to Rhenovia News Feed

Get English News Feed
Home > News & Events

News & Events

12 May 2013 - Rhenovia Pharma opens now its 2nd Round of Financing to individuals, companies and investment organizations
Article in the economic newspaper La Tribune: 2nd Round of Fund Raising targetting 2.5 million euros to accelerate research on brain diseases of the nervous system
29 April 2013 - Article in the economic newspaper La Tribune: 2nd Round of Fund Raising targetting 2.5 million euros to accelerate research on brain diseases of the nervous system
4 April 2013 - RHEDAR™: a former Phase II drug repositioned by help of biosimulation in neurodegenerative diseases presented at the Huntington’s disease congress
4 February 2013 - Press Announcement: Rhenovia recognized as the world leader in biosimulation of the central nervous system
Press article in Les Echos: Rhenovia invents the anti-Alzheimer patch
23 January 2013 - Press article in Les Echos: Rhenovia invents the anti-Alzheimer patch
10 December 2012 - Press Release: Rhenovia files two patent applications for RHEpatch™, an electronic transdermal patch for controlled drug delivery
9 November 2012 - Pre-announcement in the press: Rhenovia invented the first patch for controlled delivery of multiple drugs
21 October 2012 - Rhenovia at the forefront of scientific innovation with recent publications, posters and analysis articles now accessible in the News and Publications Section
17 October 2012 - AFM /Généthon receive the "Prix Galien France 2012" . Rhenovia Pharma, scientific board member and strategic partner of the AFM / Genethon is honored by this award.
13 October 2012 - Rhenovia presents 6 scientific communications at the 42nd Annual Meeting of the Society For Neuroscience (SFN), New Orleans, October 13-17, 2012
10 August 2012 - Rhenovia Executives for a Week at Offices in Cambridge - Boston September 10-14th, 2012
14 July 2012 - MODEL ENGINE - Biosimulation Drives Drug Discovery for Rare Diseases
10 June 2012 - Rhenovia at EuroTox 2012: Applications of the Neurotoxicity Biosimulation Platform
Rhenovia files patents for new treatment of Huntington’s disease based on its innovative biosimulation platform
7 June 2012 - Rhenovia files patents for new treatment of Huntington’s disease based on its innovative biosimulation platform
Rhenovia at BIO to present its neuronal biosimulation platforms and proof of concept by RHEDAR, a new drug candidate to treat Huntington’s Disease
2 June 2012 - Rhenovia at BIO to present its neuronal biosimulation platforms and proof of concept by RHEDAR, a new drug candidate to treat Huntington’s Disease
Rhenovia in Medical News Today: Rare, Orphan And Neglected Neurodegenerative Diseases - New Research Announced
30 April 2012 - Rhenovia in Medical News Today: Rare, Orphan And Neglected Neurodegenerative Diseases - New Research Announced
Rhenovia to BioCentury: Simultaneous launch of Orphan Disease Biosimulation Platforms and 2nd Round Table for Investors
2 April 2012 - Rhenovia to BioCentury: Simultaneous launch of Orphan Disease Biosimulation Platforms and 2nd Round Table for Investors
Rare, Orphan And Neglected Neurodegenerative Diseases - New Research Announced
24 March 2012 - Rare, Orphan And Neglected Neurodegenerative Diseases - New Research Announced
Rhenovia launches drug discovery programs in rare, orphan and neglected neurodegenerative diseases Share
24 March 2012 - Rhenovia launches drug discovery programs in rare, orphan and neglected neurodegenerative diseases Share
Rhenovia launches rare, orphan and neglected disease drug discovery
24 March 2012 - Rhenovia launches rare, orphan and neglected disease drug discovery
Monday, March 19, 2012 Rhenovia launches drug discovery for Huntington's disease By Don Seiffert, Correspondent
20 March 2012 - Monday, March 19, 2012 Rhenovia launches drug discovery for Huntington's disease By Don Seiffert, Correspondent
Pre-Announcement: Rhenovia starts the evaluation of the Second Round Table of Fund Raising for Investors
15 March 2012 - Pre-Announcement: Rhenovia starts the evaluation of the Second Round Table of Fund Raising for Investors
Use of Biosimulation to Facilitate Drug Discovery in Huntington’s Disease - Poster presented by Rhenovia Team in Palm Springs, CA, USA
7 March 2012 - Use of Biosimulation to Facilitate Drug Discovery in Huntington’s Disease - Poster presented by Rhenovia Team in Palm Springs, CA, USA
Rhenovia invited by The Russian Academy of Science in Moscow in the frame of SELFMEM as participant of a 5.2 M Euros strategic FP7 EU-Project
29 February 2012 - Rhenovia invited by The Russian Academy of Science in Moscow in the frame of SELFMEM as participant of a 5.2 M Euros strategic FP7 EU-Project
Rhenovia presents First Advancements in its Program for Rare & Neglected Diseases
19 February 2012 - Rhenovia presents First Advancements in its Program for Rare & Neglected Diseases
Clean Tuesday at Strasbourg; Presentation of Rhenovia Pharma
14 February 2012 - Clean Tuesday at Strasbourg; Presentation of Rhenovia Pharma
Rhenovia Pharma opens first US office: press news in World Pharma Today
1 February 2012 - Rhenovia Pharma opens first US office: press news in World Pharma Today
Breaking News: Rhenovia Pharma has incorporated a company in USA starting its operations in the Greater Boston Area.
6 January 2012 - Breaking News: Rhenovia Pharma has incorporated a company in USA starting its operations in the Greater Boston Area.
Rhenovia’s 2011 Assessment: Expansion of the Biosimulation Platform Strengthened by Demonstrations and Validations Highlighted in Publications and Posters.
30 December 2011 - Rhenovia’s 2011 Assessment: Expansion of the Biosimulation Platform Strengthened by Demonstrations and Validations Highlighted in Publications and Posters.
Profiling Drugs and any Active Compound and Chemical at Multiple Integrative Levels in CNS using its Multi-Scale Biosimulation Platform: A New Service Offer of Rhenovia to Optimize Pharma & Biotech Companies Drug Discovery & Development.
24 December 2011 - Profiling Drugs and any Active Compound and Chemical at Multiple Integrative Levels in CNS using its Multi-Scale Biosimulation Platform: A New Service Offer of Rhenovia to Optimize Pharma & Biotech Companies Drug Discovery & Development.
Michel Faupel Rhenovia's Vice President appointed Lecturer at University of Haute Alsace
22 December 2011 - Michel Faupel Rhenovia's Vice President appointed Lecturer at University of Haute Alsace
Rhenovia ends year 2011 with a new publication: Simulation of Postsynaptic Glutamate Receptors (especially mGluRs) Reveals Critical Features of Glutamatergic Transmission.
15 December 2011 - Rhenovia ends year 2011 with a new publication: Simulation of Postsynaptic Glutamate Receptors (especially mGluRs) Reveals Critical Features of Glutamatergic Transmission.
Rhenovia Pharma celebrates its 1st PhD Thesis: ‘Numerical Modeling and Simulation of Neural Transmission’ by Renaud Greget
25 November 2011 - Rhenovia Pharma celebrates its 1st PhD Thesis: ‘Numerical Modeling and Simulation of Neural Transmission’ by Renaud Greget
Rhenovia presents its nervous system biosimulation platform for drug discovery at the Neuroscience Meeting 2011, Washington, DC, November 12-16.
1 November 2011 - Rhenovia presents its nervous system biosimulation platform for drug discovery at the Neuroscience Meeting 2011, Washington, DC, November 12-16.
Professor Michel Baudry, Co-founder and Scientific Chief Officer at Rhenovia, appointed Dean of the Graduate College of Biomedical Sciences at Western University of Health Sciences, Pomona, Calif., USA
21 October 2011 - Professor Michel Baudry, Co-founder and Scientific Chief Officer at Rhenovia, appointed Dean of the Graduate College of Biomedical Sciences at Western University of Health Sciences, Pomona, Calif., USA
18 October 2011 - Success for Rhenovia the biosimulation specialist. This success brings Rhenovia funding of 850 000 to complete the project Rhetox, Article in French
18 October 2011 - 18 October 2011 - Success for Rhenovia the biosimulation specialist. This success brings Rhenovia funding of 850 000 to complete the project Rhetox, Article in French
Application of Rhenovia’s biosimulation platform to uncover the impact of neurotoxic airborne nanoparticles? An approach supported by a publication co-authored by Rhenovia CSO.
12 October 2011 - Application of Rhenovia’s biosimulation platform to uncover the impact of neurotoxic airborne nanoparticles? An approach supported by a publication co-authored by Rhenovia CSO.
Rhenovia invited to participate at the Economic Mission Alsace-Québec, Montréal, October 12-14, 2011
11 October 2011 - Rhenovia invited to participate at the Economic Mission Alsace-Québec, Montréal, October 12-14, 2011
Rhenovia Pharma receives the Research Tax Credit (CIR) accreditation as a research service provider
26 September 2011 - Rhenovia Pharma receives the Research Tax Credit (CIR) accreditation as a research service provider
Rhenovia’s RHETOX Project is selected by French MoD for financing of EUR 1.15 million
5 September 2011 - Rhenovia’s RHETOX Project is selected by French MoD for financing of EUR 1.15 million
GEN News Highlights: Sep 1, 2011 Rhenovia and French Army Awarded €1.15M to Develop Neurotoxin Biosimulation Platform
4 September 2011 - GEN News Highlights: Sep 1, 2011 Rhenovia and French Army Awarded €1.15M to Develop Neurotoxin Biosimulation Platform
Press Announcement: Rhenovia’s RHETOX Project is selected by France’s Ministries of Defense and Economy, for a financing of €1.15 million
2 September 2011 - Press Announcement: Rhenovia’s RHETOX Project is selected by France’s Ministries of Defense and Economy, for a financing of €1.15 million
RHENOVIA at the 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBS ’11).Boston
30 August 2011 - RHENOVIA at the 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBS ’11).Boston
Rhenovia’s President & CEO, Serge Bischoff, at the ‘European NeuroTech Investing and Partnering Summit’, Helsinki, 7-8 September 2011
29 August 2011 - Rhenovia’s President & CEO, Serge Bischoff, at the ‘European NeuroTech Investing and Partnering Summit’, Helsinki, 7-8 September 2011
Rhenovia invited to present its technological innovations in sub-cellular filtration at WFC 11 - 11th World Filtration Congress April 16,2012 - April 20,2012 Messecenter Graz, Austria, Messeplatz 1
28 August 2011 - Rhenovia invited to present its technological innovations in sub-cellular filtration at WFC 11 - 11th World Filtration Congress April 16,2012 - April 20,2012 Messecenter Graz, Austria, Messeplatz 1
Rhenovia Invited to present new Bio-simulation technologies at Biovalley /Donnerstag, 27. Oktober 2011, 18 Uhr 9. BioValley – Stammtisch in Neuenburg am Rhein. Germany
21 August 2011 - Rhenovia Invited to present new Bio-simulation technologies at Biovalley /Donnerstag, 27. Oktober 2011, 18 Uhr 9. BioValley – Stammtisch in Neuenburg am Rhein. Germany
Rhenovia invited to present its innovative biosimulation and individualized medicine approaches for the optimization of the Drug Discovery and Development at the European Neurotech Investing & Partnering Summit, September 7-8, Helsinki, Finland
31 July 2011 - Rhenovia invited to present its innovative biosimulation and individualized medicine approaches for the optimization of the Drug Discovery and Development at the European Neurotech Investing & Partnering Summit, September 7-8, Helsinki, Finland
Join Rhenovia at the partnering forum at BIO Washington DC (27-30 June 2011)
6 June 2011 - Join Rhenovia at the partnering forum at BIO Washington DC (27-30 June 2011)
Recruitment of an electrophysiologist for a Post Doctoral position
30 May 2011 - Recruitment of an electrophysiologist for a Post Doctoral position
Rhenovia enters into a strategic alliance with Portmann Instruments for marketing its biosimulation services in Switzerland
25 May 2011 - Rhenovia enters into a strategic alliance with Portmann Instruments for marketing its biosimulation services in Switzerland
Rhenovia contributes to the 4th international MYOLOGY2011 Lille congress which will be held from 9th till 13th May in the Lille Grand Palais.
9 May 2011 - Rhenovia contributes to the 4th international MYOLOGY2011 Lille congress which will be held from 9th till 13th May in the Lille Grand Palais.
Sodiaal-Candia and Rhenovia Pharma common Study. This study will use the technological expertise of Rhenovia, particularly its platform of biosimulation of pathologies of the central nervous system and peripheral, to study the influence of feeding on human health, notably on development of neurodegenerative diseases and pathologies linked to ageing.
2 May 2011 - Sodiaal-Candia and Rhenovia Pharma common Study. This study will use the technological expertise of Rhenovia, particularly its platform of biosimulation of pathologies of the central nervous system and peripheral, to study the influence of feeding on human health, notably on development of neurodegenerative diseases and pathologies linked to ageing.
Press Announcement: Rhenovia expands its fields of intervention to the prevention of neurodegenerative diseases in addition to drug treatments by signing an R&D contract with Sodiaal-Candia for studying the nutritional and therapeutic value of milk and its derivatives.
26 April 2011 - Press Announcement: Rhenovia expands its fields of intervention to the prevention of neurodegenerative diseases in addition to drug treatments by signing an R&D contract with Sodiaal-Candia for studying the nutritional and therapeutic value of milk and its derivatives.
Rhenovia Pharma SAS (France) and Portmann Instruments AG (Switzerland) start discussions to form a strategic alliance.
30 December 2010 - Rhenovia Pharma SAS (France) and Portmann Instruments AG (Switzerland) start discussions to form a strategic alliance.
Rhenovia awarded by the European regional development fund (ERDF)
15 December 2010 - Rhenovia awarded by the European regional development fund (ERDF)
AFM invests on the Rhenovia virtual model of nerve transmission to speed up drug research (source: http://www.afm-telethon.fr/)
15 December 2010 - AFM invests on the Rhenovia virtual model of nerve transmission to speed up drug research (source: http://www.afm-telethon.fr/)
Rhenovia signs two-year EUR 500,000 partnership with AFM to support its simulation technology for diseases of the nervous system
10 December 2010 - Rhenovia signs two-year EUR 500,000 partnership with AFM to support its simulation technology for diseases of the nervous system
Simulation technology for diseases of the nervous system
10 December 2010 - Simulation technology for diseases of the nervous system
Publication: Rhenovia’s Research Associate, Xiaoning Bi, MD, PhD, critically evaluates the past and new research paths for treating Alzheimer patients.
30 November 2010 - Publication: Rhenovia’s Research Associate, Xiaoning Bi, MD, PhD, critically evaluates the past and new research paths for treating Alzheimer patients.
Rhenovia honored to be presented at the Alsace Business Angels Assembly at the House of the Region in Strasbourg
23 November 2010 - Rhenovia honored to be presented at the Alsace Business Angels Assembly at the House of the Region in Strasbourg
RHENOVIA presents its biosimulation platform at four Poster Communications at the Annual Meeting of the Society for Neurosciences, San Diego, November 13-17, 2010
13 November 2010 - RHENOVIA presents its biosimulation platform at four Poster Communications at the Annual Meeting of the Society for Neurosciences, San Diego, November 13-17, 2010
Rhenovia Pharma has been honored by the visit of Mr. François Loos, Former Minister and actual Vice President of the Regional Council of Alsace
29 October 2010 - Rhenovia Pharma has been honored by the visit of Mr. François Loos, Former Minister and actual Vice President of the Regional Council of Alsace
Rhenovia Pharma at the World Expo in Shanghaï, China, in October 2010
19 October 2010 - Rhenovia Pharma at the World Expo in Shanghaï, China, in October 2010
Rhenovia welcomes Doctoriales Alsace for a one day seminar on the management of projects and innovation
15 October 2010 - Rhenovia welcomes Doctoriales Alsace for a one day seminar on the management of projects and innovation
Performing drug testing on the computer instead in bench experiment: Rhenovia presents a new tool of biosimulation at BioPharm America, 15-17 September 2010, Boston.
4 September 2010 - Performing drug testing on the computer instead in bench experiment: Rhenovia presents a new tool of biosimulation at BioPharm America, 15-17 September 2010, Boston.
DID RHENOVIA UNRAVEL THE CAUSE OF ONE OF THE MAJOR SETBACKS OF THE PHARMACEUTICAL INDUSTRY? The Rhenovia team used its modeling and biosimulation platform to explain the failures of NMDA receptor antagonists in stroke.
29 August 2010 - DID RHENOVIA UNRAVEL THE CAUSE OF ONE OF THE MAJOR SETBACKS OF THE PHARMACEUTICAL INDUSTRY? The Rhenovia team used its modeling and biosimulation platform to explain the failures of NMDA receptor antagonists in stroke.
Rhenovia invited by UBIFRANCE to present its unique neuronal biosimulation platform at the French Biotech Tour in Philadelphia, 14 September 2010.
21 August 2010 - Rhenovia invited by UBIFRANCE to present its unique neuronal biosimulation platform at the French Biotech Tour in Philadelphia, 14 September 2010.
August 20, 2010 2:36 AM ET Pharmaceuticals Rhenovia Pharma SAS:Key developments for Rhenovia Pharma cited in Bloomberg Business Week
20 August 2010 - August 20, 2010 2:36 AM ET Pharmaceuticals Rhenovia Pharma SAS:Key developments for Rhenovia Pharma cited in Bloomberg Business Week
Rhenovia hosts the 3rd Biannual Meeting of the 7th PCRD European Program SELFMEM, 6-7 September 2010 at its new headquarters in Mulhouse/France
18 August 2010 - Rhenovia hosts the 3rd Biannual Meeting of the 7th PCRD European Program SELFMEM, 6-7 September 2010 at its new headquarters in Mulhouse/France
Rhenovia simulates neurons for better drugs : demonstration in 2 videos
14 August 2010 - Rhenovia simulates neurons for better drugs : demonstration in 2 videos
Prof. Theodore Berger, Chairman of the Rhenovia Advisory Board participated at IEEE-EMBS Grand Challenges in Neuroengineering
11 August 2010 - Prof. Theodore Berger, Chairman of the Rhenovia Advisory Board participated at IEEE-EMBS Grand Challenges in Neuroengineering
Rhenovia's New Headquarters Inaugurated on July 3, 2010
5 July 2010 - Rhenovia's New Headquarters Inaugurated on July 3, 2010
Inauguration of Rhenovia New Headquarters: July 3, 2010
3 July 2010 - Inauguration of Rhenovia New Headquarters: July 3, 2010
Press Conference: Official Launch of Rhenovia's Epilepsy Program for the Optimization of Antiepileptic Drug Discovery & Development of Pharmaceutical and Biotechnology Companies.
2 June 2010 - Press Conference: Official Launch of Rhenovia's Epilepsy Program for the Optimization of Antiepileptic Drug Discovery & Development of Pharmaceutical and Biotechnology Companies.
Enhance the success rate of your in-licensing activities with the Rhenovia’s new service offer “The Virtual Compound Profiling Program” - Meet Rhenovia at BIO Chicago (3-6 May 2010), French Pavilion #3712
26 April 2010 - Enhance the success rate of your in-licensing activities with the Rhenovia’s new service offer “The Virtual Compound Profiling Program” - Meet Rhenovia at BIO Chicago (3-6 May 2010), French Pavilion #3712
DRUG DISCOVERY Rhenovia wins contract to lead USD 3.75 million biosimulation project: Rhenovia will be present at BIO Chicago, May 3-6, 2010 at booth #3712
16 April 2010 - DRUG DISCOVERY Rhenovia wins contract to lead USD 3.75 million biosimulation project: Rhenovia will be present at BIO Chicago, May 3-6, 2010 at booth #3712
Rhenovia will take the lead RHENEPI, a project of 2.5 million Euro. Objective: To develop a platform biosimulation of seizures to identify and test new drugs and optimize existing ones.
15 April 2010 - Rhenovia will take the lead RHENEPI, a project of 2.5 million Euro. Objective: To develop a platform biosimulation of seizures to identify and test new drugs and optimize existing ones.
Rhenovia to lead US$3.75m biosimulation project
15 April 2010 - Rhenovia to lead US$3.75m biosimulation project
The platform of biosimulation Rhenovia is used to simulate the neural transmission which leads to erratic seizures
15 April 2010 - The platform of biosimulation Rhenovia is used to simulate the neural transmission which leads to erratic seizures
159 press articles today regarding the news Rhenovia
14 April 2010 - 159 press articles today regarding the news Rhenovia
Collaborative project extends Rhenovia's innovative CNS biosimulation platform
13 April 2010 - Collaborative project extends Rhenovia's innovative CNS biosimulation platform
Rhenovia at BIO Chicago, May 3-6, 2010: discover the new applications of Rhenovia's biosimulation platform for the optimization of your Drug Discovery
8 April 2010 - Rhenovia at BIO Chicago, May 3-6, 2010: discover the new applications of Rhenovia's biosimulation platform for the optimization of your Drug Discovery
Meet with Rhenovia at the CHI's Combination Drug Therapies Conference (April 13-14, 2010, Philadelphia)
5 April 2010 - Meet with Rhenovia at the CHI's Combination Drug Therapies Conference (April 13-14, 2010, Philadelphia)
Rhenovia awarded by the academic authorities and the Region Alsace for its commitment to training its employees and gets the trophy in 2010
4 April 2010 - Rhenovia awarded by the academic authorities and the Region Alsace for its commitment to training its employees and gets the trophy in 2010
Pre-Announcement: Rhenovia will participate at the partnering at Bio Chicago (3-6 May 2010) and be present at the French Pavillion. One-to-one partnering can already be requested to serge.bischoff@rhenovia.com .
22 March 2010 - Pre-Announcement: Rhenovia will participate at the partnering at Bio Chicago (3-6 May 2010) and be present at the French Pavillion. One-to-one partnering can already be requested to serge.bischoff@rhenovia.com .
Rhenovia Pharma among the 75 projects of French clusters of competitiveness
17 March 2010 - Rhenovia Pharma among the 75 projects of French clusters of competitiveness
The Mechanisms of Memory:Rhenovia CSO and USC College's Pr. Michel Baudry and graduate student Sohila Zadran brought 40 years of research to a pinnacle with their breakthroughs in the science of learning and memory.
15 March 2010 - The Mechanisms of Memory:Rhenovia CSO and USC College's Pr. Michel Baudry and graduate student Sohila Zadran brought 40 years of research to a pinnacle with their breakthroughs in the science of learning and memory.
Rhenovia awarded 'entrepreneurs of exception' is selected by OSEO to join the Club Excellence
9 March 2010 - Rhenovia awarded 'entrepreneurs of exception' is selected by OSEO to join the Club Excellence
Discover Rhenovia’s breakthrough biosimulation platform to maximize your Drug Pipeline at Bio-Europe Spring in Barcelona (Spain) March 8-10, 2010
8 March 2010 - Discover Rhenovia’s breakthrough biosimulation platform to maximize your Drug Pipeline at Bio-Europe Spring in Barcelona (Spain) March 8-10, 2010
SELFMEM/ Self-assembling Polymer Membranes; a EU-FP7 co-funded project / Grant Agreement NMP3-SL-2009-228652 ( 2nd semiannual meeting ) will be held at University of Cyprus on 4 and 5 March 2010 .
5 March 2010 - SELFMEM/ Self-assembling Polymer Membranes; a EU-FP7 co-funded project / Grant Agreement NMP3-SL-2009-228652 ( 2nd semiannual meeting ) will be held at University of Cyprus on 4 and 5 March 2010 .
The CSO of Rhenovia , Pr. Michel Baudry awarded Dr. Honoris Causa from the University of Provence Aix Marseille
4 February 2010 - The CSO of Rhenovia , Pr. Michel Baudry awarded Dr. Honoris Causa from the University of Provence Aix Marseille
Join Rhenovia at the Maison de l’Alsace, on the Champs Elysées in Paris on Januray 27, 2010.
27 January 2010 - Join Rhenovia at the Maison de l’Alsace, on the Champs Elysées in Paris on Januray 27, 2010.
Rhenovia represented by Alsace BioValley at BioPartnering North America in Vancouver
25 January 2010 - Rhenovia represented by Alsace BioValley at BioPartnering North America in Vancouver
Estrogen and memory: a
10 December 2009 - Estrogen and memory: a "calpain" step closer: a new study: Pr. Michel Baudry,CSO of Rhenovia, is senior co-author of the study, which implies that the hormonal description of estrogen needs revisiting.
Rhenovia migrates its headquarters to its new premises
25 November 2009 - Rhenovia migrates its headquarters to its new premises
NewYork, Last 14-15 of September:Alzheimer's Drug Discovery Fondation Hosted the 10th International Conference on Alzheimer's Drug Discovery,Big Success for Rhenovia Pharma The 10th International Conference on Alzheimer's Drug Discovery was sponsored by Pfizer Inc.; Elan Pharmaceuticals; Martek Biosciences Corporation; Schering-Plough; Allon Therapeutics, Inc.; JSW Lifesciences; Abbott; The American Journal of Geriatric Pharmacotherapy; Apredica; Intra-Cellular Therapies, Inc.; and Rhenovia Pharma.
14 November 2009 - NewYork, Last 14-15 of September:Alzheimer's Drug Discovery Fondation Hosted the 10th International Conference on Alzheimer's Drug Discovery,Big Success for Rhenovia Pharma The 10th International Conference on Alzheimer's Drug Discovery was sponsored by Pfizer Inc.; Elan Pharmaceuticals; Martek Biosciences Corporation; Schering-Plough; Allon Therapeutics, Inc.; JSW Lifesciences; Abbott; The American Journal of Geriatric Pharmacotherapy; Apredica; Intra-Cellular Therapies, Inc.; and Rhenovia Pharma.
The collaborative project Rhenepi of Rhenovia Pharma wins today labeling of Biovalley competitivity center (on a worldwide scale)
10 November 2009 - The collaborative project Rhenepi of Rhenovia Pharma wins today labeling of Biovalley competitivity center (on a worldwide scale)
Pr. Pierre Braunstein;member of the Scientific Council of Rhenovia as keynote speaker at the Inaugural (1st) International Conference on Molecular & Functional Catalysis (ICMFC –1) @ Singapore
18 October 2009 - Pr. Pierre Braunstein;member of the Scientific Council of Rhenovia as keynote speaker at the Inaugural (1st) International Conference on Molecular & Functional Catalysis (ICMFC –1) @ Singapore
Looking Forward to Pharma's Decade of Predictive Efficacy: Rhenovia mentioned as a champion in an article published in BioPharma Today
14 October 2009 - Looking Forward to Pharma's Decade of Predictive Efficacy: Rhenovia mentioned as a champion in an article published in BioPharma Today
Meet Rhenovia: Chicago 39th annual meeting of the Society for Neuroscience.
10 October 2009 - Meet Rhenovia: Chicago 39th annual meeting of the Society for Neuroscience.
Rhenovia obtains significant research contract in the frame of the European 7PCRD
30 September 2009 - Rhenovia obtains significant research contract in the frame of the European 7PCRD
Rhenovia participates at the French economical mission in Seoul and Tokyo on October 3-9, 2009.
26 September 2009 - Rhenovia participates at the French economical mission in Seoul and Tokyo on October 3-9, 2009.
Dr.Xiaoning Bi, MD, strengthens team Rhenovia Pharma
24 September 2009 - Dr.Xiaoning Bi, MD, strengthens team Rhenovia Pharma
Toward Replacement Parts for the Brain: A best seller of the Rhenovia Scientific chairman ( Pr.Ted Berger)
21 September 2009 - Toward Replacement Parts for the Brain: A best seller of the Rhenovia Scientific chairman ( Pr.Ted Berger)
OSEO supports Rhenovia Pharma ( In French) OSEO has three jobs: * support for innovation, * guarantee bank loans and equity investors, * the partnership funding.
15 September 2009 - OSEO supports Rhenovia Pharma ( In French) OSEO has three jobs: * support for innovation, * guarantee bank loans and equity investors, * the partnership funding.
Biosimulation: The partnership program Rheddos of Rhenovia cited in Wikipedia
21 August 2009 - Biosimulation: The partnership program Rheddos of Rhenovia cited in Wikipedia
In French: © Dernières Nouvelles d'Alsace, Jeudi 13 Août 2009:Business angels invest in Rhenovia
16 August 2009 - In French: © Dernières Nouvelles d'Alsace, Jeudi 13 Août 2009:Business angels invest in Rhenovia
Two USC faculty members and the French drug discovery company Rhenovia Pharma have been awarded a biomedical research partnership by the National Institutes of Health.The grant will support joint research by the three partners for four years, with the total amount of funding reaching $2.3 million.
16 August 2009 - Two USC faculty members and the French drug discovery company Rhenovia Pharma have been awarded a biomedical research partnership by the National Institutes of Health.The grant will support joint research by the three partners for four years, with the total amount of funding reaching $2.3 million.
Meet with Rhenovia :BioValley-Stammtisch Freiburg in Germany: Rhenovia Pharma: Innovative Drug Discovery and Development by a Breakthrough Biosimulation Technology
15 August 2009 - Meet with Rhenovia :BioValley-Stammtisch Freiburg in Germany: Rhenovia Pharma: Innovative Drug Discovery and Development by a Breakthrough Biosimulation Technology
Rhenovia registered in Bionity.com
15 August 2009 - Rhenovia registered in Bionity.com
ECOBANK says today: France: The eastern and northern regions have companies with strong potential; Example: Rhenovia in Mulhouse
11 August 2009 - ECOBANK says today: France: The eastern and northern regions have companies with strong potential; Example: Rhenovia in Mulhouse
Science Business News : Rhenovia Pharma | France | Funding Rhenovia raises €390K in angel funding
7 August 2009 - Science Business News : Rhenovia Pharma | France | Funding Rhenovia raises €390K in angel funding
From
7 August 2009 - From "Wherepharmameets News":Rhenovia Closes First Round of Angel Funding
NIH to Fund Bioinformatics Small Business Grants August 05, 2009 A trans-NIH program will support SBIR, STTR, and research grants in computational biology. France's Rhenovia Pharma Raises $540K to Advance USC Simulation Tech as Drug-Discovery Tool August 04, 2009 By Ben Butkus
5 August 2009 - NIH to Fund Bioinformatics Small Business Grants August 05, 2009 A trans-NIH program will support SBIR, STTR, and research grants in computational biology. France's Rhenovia Pharma Raises $540K to Advance USC Simulation Tech as Drug-Discovery Tool August 04, 2009 By Ben Butkus
Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders GEN News Highlights
4 August 2009 - Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders GEN News Highlights
Rhenovia signs research contract with USC and NIH
4 August 2009 - Rhenovia signs research contract with USC and NIH
Extra on line magazine Capital (August 2009) Rhenovia ranked one of the most promising start-up in France
1 August 2009 - Extra on line magazine Capital (August 2009) Rhenovia ranked one of the most promising start-up in France
Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA
1 August 2009 - Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA
Rhenovia and USC labs in US$2.3m biosimulation research programme
1 August 2009 - Rhenovia and USC labs in US$2.3m biosimulation research programme
176 articles have been published this July in the international business press highlighting successful cases Rhenovia Pharma
1 August 2009 - 176 articles have been published this July in the international business press highlighting successful cases Rhenovia Pharma
Rhenovia wins angel funding (art.in Growthbusiness.UK 31.07.09)
31 July 2009 - Rhenovia wins angel funding (art.in Growthbusiness.UK 31.07.09)
Dow Jones Industrial Average:Rhenovia Pharma SAS, a biopharmaceutical company developing drugs for Alzheimer's and other brain diseases, said it has raised EUR390,000 ($542,000) in a first round of angel funding..
31 July 2009 - Dow Jones Industrial Average:Rhenovia Pharma SAS, a biopharmaceutical company developing drugs for Alzheimer's and other brain diseases, said it has raised EUR390,000 ($542,000) in a first round of angel funding..
Rhenovia obtains significant research contract with the US National Institutes of Health (NIH)
31 July 2009 - Rhenovia obtains significant research contract with the US National Institutes of Health (NIH)
Pharmalive.com. Rhenovia obtains significant research contract with the US National Institutes of Health (NIH)
30 July 2009 - Pharmalive.com. Rhenovia obtains significant research contract with the US National Institutes of Health (NIH)
USC partners with French drug discovery company on computer modeling effort
30 July 2009 - USC partners with French drug discovery company on computer modeling effort
Jul 29 2009, 10:22 AM EST Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders GEN News Highlights
30 July 2009 - Jul 29 2009, 10:22 AM EST Rhenovia and USC to Collect $2.3M Grant to Study Brain Functions and Disorders GEN News Highlights
Rhenovia ranked one of the most promising start-up in France
21 July 2009 - Rhenovia ranked one of the most promising start-up in France
RHENOVIA PHARMA has completed successfully its first round table of private fund raising.
11 July 2009 - RHENOVIA PHARMA has completed successfully its first round table of private fund raising.
Rhenovia opens its biosimulation platform...
10 July 2009 - Rhenovia opens its biosimulation platform...
Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA
10 July 2009 - Meet with the Rhenovia Pharma Team at the 39th Meeting of the Society for Neuroscience, October 17-21, 2009, Chicago, Illinois, USA
Rhenovia Closes First Round of Angel Funding
7 July 2009 - Rhenovia Closes First Round of Angel Funding
Rhenovia funded by the European FP7 Research Programme
6 July 2009 - Rhenovia funded by the European FP7 Research Programme
Rhenovia Pharma at Bio Atlanta international convention 18-21 of May
18 May 2009 - Rhenovia Pharma at Bio Atlanta international convention 18-21 of May
BME Part of NIH-Funded $2.3M Partnership to Research Glutamate Receptor Activity
26 April 2009 - BME Part of NIH-Funded $2.3M Partnership to Research Glutamate Receptor Activity
Visit of the french Secretary of State for Development of Digital Economy,and meeting with Dr. Serge Bischoff
13 April 2009 - Visit of the french Secretary of State for Development of Digital Economy,and meeting with Dr. Serge Bischoff
meet Rhenovia at Bio Square, March 9-11 Lyon congress center
9 March 2009 - meet Rhenovia at Bio Square, March 9-11 Lyon congress center
Rhenovia at Neuroscience 2008 Washington DC: 15-19 November
15 November 2008 - Rhenovia at Neuroscience 2008 Washington DC: 15-19 November
Rhenovia at MIPTEC Basel 14-16 October 2008
14 October 2008 - Rhenovia at MIPTEC Basel 14-16 October 2008
EUROBIO 2008 Paris: Meet and partner with Rhenovia in Paris 7-9 October
7 October 2008 - EUROBIO 2008 Paris: Meet and partner with Rhenovia in Paris 7-9 October
Meet with Rhenovia at BioContact Quebec October 1-3, 2008
1 October 2008 - Meet with Rhenovia at BioContact Quebec October 1-3, 2008
Partnership between Altran Est (The european leader in innovation consulting) and Rhenovia Pharma
19 September 2008 - Partnership between Altran Est (The european leader in innovation consulting) and Rhenovia Pharma
Dr. Serge Braun : New scientific advisory board member of Rhenovia
25 July 2008 - Dr. Serge Braun : New scientific advisory board member of Rhenovia
Eurostars label for Rhenovia Pharma
22 July 2008 - Eurostars label for Rhenovia Pharma
Rhenovia and the Blue Brain Project Meeting: in Geneva
10 July 2008 - Rhenovia and the Blue Brain Project Meeting: in Geneva
Rhenovia invited by the French government at the European Innovation Conférence
7 July 2008 - Rhenovia invited by the French government at the European Innovation Conférence
Rhenovia presents the EONS-RHENOMS platform at the 3rd Frontiers in Biomedical Devices Conference, a congress of the ASME, the American Society for Medical Engineering
18 June 2008 - Rhenovia presents the EONS-RHENOMS platform at the 3rd Frontiers in Biomedical Devices Conference, a congress of the ASME, the American Society for Medical Engineering
Rhenovia obtains Eurostars Label from the European Community
10 June 2008 - Rhenovia obtains Eurostars Label from the European Community
Rhenovia at BioBAC Conference Basel
4 June 2008 - Rhenovia at BioBAC Conference Basel
just married
23 May 2008 - just married
Rhenovia invited to Region Alsace
21 April 2008 - Rhenovia invited to Region Alsace
Participation of Rhenovia: April 17, 2008, 3rd Leadership Course: European Course for Life Sciences Executives
17 April 2008 - Participation of Rhenovia: April 17, 2008, 3rd Leadership Course: European Course for Life Sciences Executives
Pr. Henry Markram; New scientific advisory board member of Rhenovia
8 April 2008 - Pr. Henry Markram; New scientific advisory board member of Rhenovia
Rhenovia at BioSquare Basel 2008
12 March 2008 - Rhenovia at BioSquare Basel 2008
Highly Cited Researchers: Pr. Michel Baudry co-founder of Rhenovia
28 February 2008 - Highly Cited Researchers: Pr. Michel Baudry co-founder of Rhenovia
Partnership with the Association Alsace Alzheimer 68
21 February 2008 - Partnership with the Association Alsace Alzheimer 68
15 October 2007 - Novel Drug Discovery Strategy for Alzheimer's and Other Brain Diseases
Colloque ECRIN PARIS: Vers une standardisation en biologie : Enjeux scientifiques et économiques
9 October 2007 - Colloque ECRIN PARIS: Vers une standardisation en biologie : Enjeux scientifiques et économiques
Biovalley news
10 July 2007 - Biovalley news
 
News

News & Events

May 2013 - Rhenovia Pharma opens now its 2nd Round of Financing to individuals, companies and investment organizations

Apr 2013 - Article in the economic newspaper La Tribune: 2nd Round of Fund Raising targetting 2.5 million euros to accelerate research on brain diseases of the nervous system

Press Releases

Feb 2013 - Press announcement: Rhenovia Pharma recognized as the world leader in biosimulation of the central nervous system

Nov 2012 - Press announcement: Rhenovia files two patent applications for RHEpatch™

Publications

Modeling & Simulation: CNS – Targeted Approach.

Model Behavior – Biosimulation offers a cost effective way of modeling complex data on rare and orphan diseases, offering hope for drug discovery and repositioning in the field.

Newsletters

Rhenovia Receives €2.5M to Further Develop Its Biosimulation Platform GEN News Highlights

Newsletter April 2008

    
    © 2013 Rhenovia Pharma - Limited. All Rights Reserved. Use of this website is governed by our Terms of Use.